期刊文献+

卵巢交界性上皮肿瘤12例临床分析

下载PDF
导出
机构地区 临安市中医院
出处 《浙江医学》 CAS 2004年第8期620-621,共2页 Zhejiang Medical Journal
  • 相关文献

参考文献9

  • 1糜若然,瞿全新.卵巢交界性瘤[J].中国实用妇科与产科杂志,2003,19(8):460-462. 被引量:4
  • 2乐杰主编.妇产科学.第4版.北京:人民卫生出版社,1996.305.
  • 3Chambers JT. Borderline ovarian tumors: a review of treatment.Yole J Biol Med,1989,62(3):351.
  • 4Gershenson DM, Silva EG, Tortolero-Luna G, et al. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer, 1998, 83(10): 2157.
  • 5Tazelear HD, Bostwick DG, Ballon SC, et al. Conservative treatment of borderline ovarian tumors, Obstet Gynecol, 1985,66(3):417.
  • 6张震宇,洪婉君,李凌.卵巢交界性肿瘤的临床特征及治疗[J].中华妇产科杂志,1998,33(9):556-559. 被引量:34
  • 7温宏武,彭兰菊.卵巢交界性上皮性肿瘤50例诊断及治疗探讨[J].中国实用妇科与产科杂志,2001,17(11):663-665. 被引量:4
  • 8Trope C, kaem, Vergote IB. Are borderline tumors of the ovary overtreated both surgically systemically:a review of four prospective randomixed trials including 253 patients with borderline tumors. Gynecol Oncol, 1993, 51(2): 236.
  • 9李自新,秋肖凡.卵巢交界性上皮性肿瘤的治疗方式及预后[J].中华妇产科杂志,1994,29(4):207-209. 被引量:7

二级参考文献14

  • 1糜若然主编.妇科肿瘤基因诊断与治疗[M].北京:人民卫生出版社,2002..
  • 2Zanotti KM, Hart WR, Kennedy AW, et al. Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors. Int J Gynecol Pathol,1999,18(3) :247.
  • 3Hu J, Khanna MM, Surti U. Genomic imbalances in ovarian borderline serous and mucinous tumors. Cancer Genet Cytogenet, 2002,139(1) :18.
  • 4Kiziridou AD,Toliou T, Stefanou D, et al. u-PA expression in benign, borderline and malignant ovarian tumors. Anticancer Res,2002,22(2A) :958.
  • 5Deavers MT, Gershenson DM,Torrolero-Luna G, et al. Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential :a study of 99 advanced stage cases. Am J Surg Pathol,2002,26(9) :1129.
  • 6Gotlieb WH, Soriano D, Achiron R, et al. CA125 measurement and ultrasonography in borderline tumors of the ovary. Am J Obstet Gynecol,2000,183 (3) :541.
  • 7Engelen MJ,de Bruijn HW,Hollema H,et al. Serum CA125 carcinomoryonic antigen,and CA19-9 as tumor markers in borderline ovarian. Gynecol 0ncol,2002,28( 1 ) :16.
  • 8Camatte S, Morice P, Atallah D, et al. Lymph node disorders and prognostic value of nodal involvement in patients treated for a borderline ovarian tumor:an analysis of a series of 42 lymphadenectomies. J Am Coll Surg,2002,195(3) :332.
  • 9朱关珍,中华妇产科杂志,1988年,23卷,25页
  • 10连利娟,林巧稚妇科肿瘤学(第2版),1994年,453页

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部